These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3190757)

  • 1. Protection of cardiac membrane phospholipid against oxidative injury by calcium antagonists.
    Janero DR; Burghardt B; Lopez R
    Biochem Pharmacol; 1988 Nov; 37(21):4197-203. PubMed ID: 3190757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of cardioprotective cyclooxygenase and lipoxygenase inhibitors on peroxidative injury to myocardial-membrane phospholipid.
    Janero DR; Burghardt B; Lopez R; Cardell M
    Biochem Pharmacol; 1989 Dec; 38(24):4381-7. PubMed ID: 2557848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of rat myocardial phospholipid against peroxidative injury through superoxide-(xanthine oxidase)-dependent, iron-promoted Fenton chemistry by the male contraceptive gossypol.
    Janero DR; Burghardt B
    Biochem Pharmacol; 1988 Sep; 37(17):3335-42. PubMed ID: 2840914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant effect of calcium antagonists on microsomal membranes isolated from different brain areas.
    Gonçalves T; Carvalho AP; Oliveira CR
    Eur J Pharmacol; 1991 Nov; 204(3):315-22. PubMed ID: 1773831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidant effects of calcium antagonists on rat myocardial membrane lipid peroxidation.
    Sugawara H; Tobise K; Kikuchi K
    Hypertens Res; 1996 Dec; 19(4):223-8. PubMed ID: 8986452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of calcium channel blockers on superoxide anions.
    Shridi F; Robak J
    Pharmacol Res Commun; 1988 Jan; 20(1):13-21. PubMed ID: 2836871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel 6-hydroxychroman-2-carbonitrile inhibitors of membrane peroxidative injury.
    Janero DA; Cohen N; Burghardt B; Schaer BH
    Biochem Pharmacol; 1990 Aug; 40(3):551-8. PubMed ID: 2166516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiperoxidant effects of dihydropyridine calcium antagonists.
    Janero DR; Burghardt B
    Biochem Pharmacol; 1989 Dec; 38(23):4344-8. PubMed ID: 2597206
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of oxidative injury to cardiac phospholipid by membrane-active "stabilizing agents".
    Janero DR; Burghardt B
    Res Commun Chem Pathol Pharmacol; 1989 Feb; 63(2):163-73. PubMed ID: 2711024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of antioxidant effects of nifedipine and diltiazem on myocardial membrane lipid peroxidation in contrast with those of nisoldipine and propranolol.
    Sugawara H; Tobise K; Onodera S
    Biochem Pharmacol; 1994 Mar; 47(5):887-92. PubMed ID: 8135864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection by Ca2+ channel blockers (nifedipine, diltiazem and verapamil) against the toxicity of oxidized low density lipoprotein to cultured lymphoid cells.
    Nègre-Salvayre A; Salvayre R
    Br J Pharmacol; 1992 Nov; 107(3):738-44. PubMed ID: 1472971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of verapamil, gallopamil, diltiazem and nifedipine on sarcoplasmic reticulum function in rat heart.
    Zucchi R; Limbruno U; Ronca-Testoni S; Yu G; Galbani P; Ronca G; Mariani M
    Cardioscience; 1992 Sep; 3(3):167-72. PubMed ID: 1330045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Ca2+ channel antagonists and benzodiazepine receptor ligands in normal and skinned rat urinary bladder.
    Martí-Cabrera M; Llopis P; Abengochea A; Ortiz JL; Climent VJ; Cortijo J; Morcillo EJ
    Eur J Pharmacol; 1994 Apr; 255(1-3):157-65. PubMed ID: 8026541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential actions of calcium antagonists on calcium binding to cardiac sarcolemma.
    Pang DC; Sperelakis N
    Eur J Pharmacol; 1982 Jul; 81(3):403-9. PubMed ID: 6981516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of cardiac sarcolemmal Na+-Ca2+ exchange by diltiazem and verapamil.
    Takeo S; Elimban V; Dhalla NS
    Can J Cardiol; 1985 Mar; 1(2):131-8. PubMed ID: 2996725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slow calcium channel blockers and calmodulin. Effect of felodipine, nifedipine, prenylamine and bepridil on cardiac sarcolemmal calcium pumping ATPase.
    Lamers JM; Cysouw KJ; Verdouw PD
    Biochem Pharmacol; 1985 Nov; 34(21):3837-43. PubMed ID: 2933041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium channel antagonists and human immunodeficiency virus coat protein-mediated neuronal injury.
    Lipton SA
    Ann Neurol; 1991 Jul; 30(1):110-4. PubMed ID: 1656845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of calcium channel inhibition by phenytoin: comparison with classical calcium channel antagonists.
    Messing RO; Carpenter CL; Greenberg DA
    J Pharmacol Exp Ther; 1985 Nov; 235(2):407-11. PubMed ID: 2414431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative antioxidant activities of propranolol, nifedipine, verapamil, and diltiazem against sarcolemmal membrane lipid peroxidation.
    Mak IT; Weglicki WB
    Circ Res; 1990 May; 66(5):1449-52. PubMed ID: 2335037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of canine cardiac sarcoplasmic reticulum Ca2+ uptake by dihydropyridine Ca2+ antagonists.
    Movsesian MA; Ambudkar IS; Adelstein RS; Shamoo AE
    Biochem Pharmacol; 1985 Jan; 34(2):195-201. PubMed ID: 3155615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.